Fig. 3
From: Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease

Cost-saving and additional expenditure in chronic ischemic heart disease subcohort
From: Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease
Cost-saving and additional expenditure in chronic ischemic heart disease subcohort